Skip to main content
Log in

ASO Author Reflections: MRI-Derived Biomarker to Select Optimal Treatment for Esophageal Cancer Patients

  • ASO Author Reflections
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

References

  1. Hayano K, Ohira G, Hirata A, et al. Imaging biomarkers for the treatment of esophageal cancer. World J Gastroenterol. 2019;25(24):3021–9. https://doi.org/10.3748/wjg.v25.i24.3021

    Article  Google Scholar 

  2. Ganeshan B, Miles KA. Quantifying tumour heterogeneity with CT. Cancer Imaging. 2013;13(1):140–9. https://doi.org/10.1102/1470-7330.2013.0015

    Article  PubMed  PubMed Central  Google Scholar 

  3. Hirata A, Hayano K, Ohira G, et al. Volumetric histogram analysis of apparent diffusion coefficient as a biomarker to predict survival of esophageal cancer patients. Ann Surg Oncol. (in press).

  4. Hirata A, Hayano K, Ohira G, et al. Volumetric histogram analysis of apparent diffusion coefficient for predicting pathological complete response and survival in esophageal cancer patients treated with chemoradiotherapy. Am J Surg. 2019; https://doi.org/10.1016/j.amjsurg.2019.07.040

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Koichi Hayano MD, PhD, FACS.

Ethics declarations

Disclosures

Koichi Hayano, Atsushi Hirata, and Hisahiro Matsubara declare no conflicts of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hayano, K., Hirata, A. & Matsubara, H. ASO Author Reflections: MRI-Derived Biomarker to Select Optimal Treatment for Esophageal Cancer Patients. Ann Surg Oncol 27, 3090–3091 (2020). https://doi.org/10.1245/s10434-020-08298-9

Download citation

  • Received:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-08298-9

Navigation